1994 – First patent for safety lancet in the US

2000:

• Founding of the Company under the name HTL-STREFA
• Opening of first manufacturing plant within the Lodz Economic Zone
• High-volume production of safety lancets for the global market

2004 – Introduction of lancets for personal use

2006 – Initial public offering on Warsaw Stock Exchange

2007:

• Launch of second production facility with own needle grindery
• Acquisition of significant Swedish competition – Haemedic AB
• Establishment of US subsidiary – HTL-STREFA, Inc. based in Marietta, GA, USA

2009 – EQT V (leading private equity player) ownership

2010 – Withdrawal of HTL-STREFA from Warsaw Stock Exchange (due to acquisition by the EQT V)

• Two modern production facilities in Lodz Special Economic Zone, Poland
• Two Sales & Marketing offices in two locations (Warsaw, Poland and Marietta, GA, USA)
• 5 product categories with multiple variations
• Introduction of new innovative solutions into the market
• Global market presence – more than 80 countries around the world

2018 – Investindustrial (leading independent European Investment Group) ownership. Integration of HTL-STREFA and PIC